FDA Expands Use for NuVasive’s Magnetic Limb Device
NuVasive received expanded 510(k) clearance for its magnetic limb lengthening technology.
The PRECICE system was previously approved for femur and tibia limb lengthening. The new indications for use include fracture fixation, pseudoarthrosis and bone transport, which allows for bony tissue to be regenerated.
The implantable platform uses an external remote controller for non-invasive, customizable treatments on long bones using an internal gear system that can be controlled remotely with permanent magnets.